mHam 2.0 – Complement-Dependent Cell Killing Assay

About Machaon Diagnostics

Machaon Diagnostics operates a dual business model as a specialized reference lab and a contract research organization (CRO) for rare diseases. The company has carved a niche by offering the 'fastest-in-the-nation' lab services for complex, life-threatening conditions like thrombotic microangiopathies (TMA), complement disorders, and cytokine release syndrome (CRS). Its value proposition centers on speed, quality, and consistency, serving both clinicians for patient diagnosis and biopharma companies for clinical trial support. Machaon appears to be a private, revenue-generating company leveraging its diagnostic expertise to support drug development and improve patient outcomes.

Therapeutic Areas

Other Complement-mediated diseases Drugs